Mannitol is a type of sugar that your body doesn't really use for energy. Doctors sometimes give it to people with kidney problems to help their kidneys work better or to reduce swelling in the brain. It's also used in labs to study cells.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Mannitol is a sugar alcohol used as a medicine in two very different ways. Most often it is given through an IV in the hospital, sold as Osmitrol and as generic mannitol injection, to lower dangerous pressure inside the skull or the eye. Doctors use it when brain swelling (cerebral edema) from a head injury or another brain problem raises the pressure on the brain, and to bring down high pressure inside the eye, including before eye surgery. It is approved for both adults and children. An inhaled powder form, Bronchitol, is approved as an add-on maintenance treatment to improve lung function in adults 18 and older with cystic fibrosis, a genetic disease that leaves thick, sticky mucus in the lungs. A separate inhaled product, Aridol, is not a treatment at all: lung specialists use it as a one-time breathing test to check whether the airways overreact, as part of working out whether someone has asthma. Mannitol is sometimes described as a diuretic (a medicine that makes you pass more urine), and it does have that effect. It is not, however, used to treat everyday swelling or high blood pressure.
Given by IV, mannitol stays in the bloodstream and the fluid around cells rather than entering them. This makes the blood more concentrated, so water is drawn out of swollen tissue, including the brain and the eye, and into the blood vessels. That shift lowers the pressure inside the skull or eye. The kidneys then filter mannitol out but cannot reabsorb it, so it carries extra water and salt with it into the urine. That is why people produce a large amount of urine during treatment. Inhaled mannitol works on the airways rather than the whole body. The manufacturer states that exactly how it improves lung function in cystic fibrosis is not known. In the Aridol breathing test, inhaled mannitol acts as an airway irritant, and doctors measure how much the airways narrow in response.
IV mannitol is given only in a hospital or surgical setting, usually as a 10% or 20% solution infused over about 30 minutes, preferably through a large central vein because the concentrated fluid can irritate smaller veins. Before starting, the team checks kidney, heart and lung function and corrects any fluid or salt problems. For brain swelling, doses may be repeated every 6 to 8 hours. For eye pressure, it is usually a single dose, given about 60 to 90 minutes before surgery when used to prepare for an operation. The dose is calculated by body weight and adjusted to the situation, so patients and families are not expected to manage it themselves. Bronchitol comes as capsules of dry powder taken with a small handheld inhaler. Before it can be prescribed, a person must pass a Bronchitol Tolerance Test: the first dose is inhaled in a clinic while the team measures breathing and oxygen levels, ready to treat any airway tightening. About 8% of people in the clinical trials did not pass or complete this test. People who pass inhale the contents of 10 capsules, one at a time, twice a day, with the evening dose at least 2 to 3 hours before bed. A short-acting rescue inhaler such as albuterol must be used 5 to 15 minutes before every dose to help keep the airways open. The inhaler device is replaced after 7 days of use.
With IV mannitol, frequent urination is expected, and thirst and a dry mouth are common. The concentrated solution can irritate the vein and cause pain, redness or swelling at the IV site, and fluid that leaks out of the vein can cause serious tissue damage, so pain or swelling at the site should be reported to the nurse straight away. The more serious risks are why IV mannitol is closely monitored. It can shift fluid and salts in either direction, causing dehydration, or the opposite, too much fluid in the bloodstream that can strain the heart and fill the lungs, along with high or low sodium and potassium. It can injure the kidneys, occasionally permanently, especially in people who already have kidney disease. Confusion, unusual drowsiness or seizures can develop, particularly when the kidneys are not clearing the drug well, and pressure in the skull can rise again several hours after a dose. Serious allergic reactions, including anaphylaxis, are rare but have been reported, and the infusion is stopped immediately if one begins. With Bronchitol, the most common effects are cough, throat irritation, vomiting, fever and joint pain. The two that matter most are bronchospasm, a sudden tightening of the airways that causes wheezing, chest tightness or trouble breathing, and coughing up blood. Either one means stopping Bronchitol and contacting the care team right away. Bronchospasm can happen even in people who passed the tolerance test, and the rescue inhaler is the first treatment for it.
IV mannitol is not used in people who are making no urine at all (anuria), who are severely dehydrated or have very low blood volume, who already have severe fluid in the lungs, or who have active bleeding inside the skull, except during brain surgery. Kidney disease, heart failure and older age call for extra caution, and children under 2, especially newborns, are more prone to fluid and salt imbalances. Some medicines change how risky mannitol is. Drugs that can harm the kidneys, such as aminoglycoside antibiotics (for example gentamicin) and cyclosporine (an immune-suppressing drug used after transplants), and other diuretics raise the risk of kidney injury. People who take lithium, a mood stabilizer for bipolar disorder, can develop lithium toxicity if mannitol leaves them dehydrated or affects their kidneys, so lithium may be held and blood levels checked. Shifts in potassium can also affect the heart in people taking digoxin (a heart rhythm medicine) or drugs that affect heart rhythm. In practice, these combinations are managed by the hospital team, but it helps if family members can share an accurate medication list. Mannitol crosses the placenta and can cause fluid shifts in the baby. Decades of use have not shown a clear link to birth defects or miscarriage, so in pregnancy the decision weighs the mother's urgent need against this possible effect. Aridol is used only in a lung function lab and carries a boxed warning, the most prominent warning the US Food and Drug Administration puts on a drug label, because inhaling mannitol can trigger severe airway narrowing. It is not done in people with obvious asthma or very poor lung function.
For most people, IV mannitol is one part of urgent hospital care, often in an intensive care unit or operating room, and the patient may be too unwell to notice it. Families can expect frequent blood tests for sodium, potassium and the concentration of the blood, careful tracking of urine output, and sometimes direct pressure monitoring inside the skull. Its effect is temporary, which is why doses may be repeated every several hours. It treats the pressure, not the underlying injury or disease. Many hospitals use hypertonic saline, a concentrated salt solution, as an alternative; studies in traumatic brain injury suggest the two lower brain pressure about equally, with mannitol's effect tending to be shorter, and the choice depends on the patient's fluid status, kidneys and blood sodium. With Bronchitol, the goal is a small, steady improvement rather than a dramatic change. In the main trial, adults gained on average about 50 mL more in FEV1 (forced expiratory volume in one second, the amount of air a person can blow out in the first second of a hard breath) than people using a very low control dose. Response varies, and the care team uses repeat lung function tests to judge whether it is worth continuing. The twice-daily routine of a rescue inhaler followed by 10 separate capsules takes time, and fitting it in alongside other cystic fibrosis treatments is part of the decision.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mannitol, what you've noticed, or ask the community a question.